Bilateral lymphoblastic lymphoma of the breast

Deutsche medizinische Wochenschrift
H StrengS Stojakowits

Abstract

A 21-year-old female patient presenting with bilateral lymphoblastic lymphoma of the breast was given two four-week courses of cytostatic therapy using the ALL/AUL protocol. Radiation therapy was used as an adjunct. Treatment resulted in tumour regression. In the course of continued maintenance therapy neither computed tomography nor mammography nor clinical examination have so far detected any residues of a non-Hodgkin's lymphoma. It has, therefore, so far been possible to spare this young patient the mutilating consequences of mastectomy. Up to now, 27 months following start of therapy, she is again actively pursuing her professional career. There has so far been no indication of a recurrence of the lymphoma.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
K el KhaderA Lakrissa
British Journal of Hospital Medicine
C Dean
Annals of Oncology : Official Journal of the European Society for Medical Oncology
D ReH Tesch
Hinyokika kiyo. Acta urologica Japonica
M MasuiK Nagao
© 2021 Meta ULC. All rights reserved